ACM
GH icon

Asymmetry Capital Management’s Guardant Health GH Stock Holding History

Asymmetry Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,443
Closed -$3.04M – 37
2021
Q2 		$3.04M Sell
24,443
-37,466
-61% -$5.04M 2.09% 18
2021
Q1 		$9.45M Sell
61,909
-17,330
-22% -$2.62M 4.89% 9
2020
Q4 		$10.2M Buy
79,239
+10,376
+15% +$1.19M 4.66% 7
2020
Q3 		$7.7M Sell
68,863
-27,176
-28% -$2.49M 4.95% 5
2020
Q2 		$7.79M Buy
96,039
+19,601
+26% +$1.58M 5.97% 5
2020
Q1 		$5.32M Buy
76,438
+41,202
+117% +$3.16M 5.82% 4
2019
Q4 		$2.75M Buy
+35,236
New +$2.54M 4.93% 4

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Asymmetry Capital Management's GH Position: Q3 2021 in Review

Asymmetry Capital Management sold out of Guardant Health (GH) in Q3 2021, closing a stake of 24,443 shares — an estimated $3.04M sold.

Asymmetry Capital Management first reported a position in GH in Q4 2019 and held it in 7 quarters. The position peaked at $10.2M in Q4 2020. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Asymmetry Capital Management reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 24,443 Guardant Health shares in Q3 2021, an estimated $3.04M.
  • Asymmetry Capital Management first reported a position in Guardant Health in Q4 2019 and held it in 7 quarters.
  • Asymmetry Capital Management's Guardant Health position peaked at $10.2M in Q4 2020.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Asymmetry Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.